These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [Use of indirect anticoagulants]. Niedner R; Meyer F Z Allgemeinmed; 1974 Nov; 50(32):1471-6. PubMed ID: 4139825 [No Abstract] [Full Text] [Related]
5. Studies in intravascular coagulation. II. A comparison of the effect of dicumarol and heparin on clot formation in isolated venous segments. WESSLER S J Clin Invest; 1953 Jul; 32(7):650-4. PubMed ID: 13069611 [No Abstract] [Full Text] [Related]
6. Use of the anti-coagulants, heparin and dicumarol. LUCIA SP Calif Med; 1946 Jul; 65():5-8. PubMed ID: 20999619 [No Abstract] [Full Text] [Related]
7. A comparison of heparin and bishydroxycoumarin (dicumarol) as anticoagulants; resistance to tissue thromboplastin. BELKO JS; WARREN R AMA Arch Surg; 1957 Jan; 74(1):50-8. PubMed ID: 13381297 [No Abstract] [Full Text] [Related]
8. Observations on ethylidene dicoumarin as an anticoagulant, with special reference to puerperal patients. ROSE WM; KRIEGER VI Med J Aust; 1951 Dec; 2(24):813-7. PubMed ID: 14909857 [No Abstract] [Full Text] [Related]
9. The effect of dicumarol on certain factors of blood coagulation. SHANBERGE JN J Lab Clin Med; 1956 Aug; 48(2):218-22. PubMed ID: 13346188 [No Abstract] [Full Text] [Related]
10. [Theory and practice of blood coagulation. III. Therapeutic use of heparine and dicumarol]. OSTEN W Dtsch Med J; 1952 May; 3(9-10):209-12. PubMed ID: 14954830 [No Abstract] [Full Text] [Related]
11. Can we look forward to better anticoagulants than heparin and dicumarol? LINK KP Bull Chic Med Soc; 1949 Mar; 51(39):748. PubMed ID: 18124964 [No Abstract] [Full Text] [Related]
12. [Indications and contraindications for anticoagulant therapy in the light of coagulation physiology]. DE NICOLA P Schweiz Med Wochenschr; 1954 Jul; 84(29):835-8. PubMed ID: 13195640 [No Abstract] [Full Text] [Related]
13. [Modifications of heparin activity by dicumarol and ferula]. PANELLA I Boll Soc Ital Biol Sper; 1951; 27(4):526-9. PubMed ID: 14869447 [No Abstract] [Full Text] [Related]
14. Rise of blood antithrombin level during coumarin therapy. Péter M Ther Hung; 1965; 13(2):53-5. PubMed ID: 5844087 [No Abstract] [Full Text] [Related]
15. [Anticoagulants and their use]. JORDAN FL Geneeskd Bl; 1950; 44(7):193-234. PubMed ID: 14793702 [No Abstract] [Full Text] [Related]
17. The physiology of intravascular coagulation in health and disease: with reference to safeguards and hazards in the prophylactic and therapeutic use of heparin and dicumarol. ALLEN JG; MOULDER PV; ENERSON DM; BASINGER C; LANDY JJ; GLOTZER DJ Surg Clin North Am; 1957 Oct; 37(5):1473-506. PubMed ID: 13467718 [No Abstract] [Full Text] [Related]
18. [ANTICOAGULANTS. 1. BLOOD COAGULATION AND ITS MODIFICATION BY COUMARINS AND INDANDIONES]. REPPEL L Pharmazie; 1963 Jun; 18():381-91. PubMed ID: 14061154 [No Abstract] [Full Text] [Related]
19. The reduction of platelet cofactor II (autoprothrombin II) activity with anticoagulants. JOHNSON SA; SEEGERS WH; KOPPEL JL; OLWIN JH Thromb Diath Haemorrh; 1957 Aug; 1(2):158-68. PubMed ID: 13580985 [No Abstract] [Full Text] [Related]
20. [The method for separation of heparin and coumarin effect]. BELLER FK Arztl Wochensch; 1954 Dec; 9(49):1159-63. PubMed ID: 13206927 [No Abstract] [Full Text] [Related] [Next] [New Search]